[Laparoscopic gastric banding--where are the limits?].
The criteria for the indication of gastric banding (GB) or bypass in morbidly obese patients are poorly defined in the available guidelines and usually rely on the BMI of the patients.In this study, the role of the BMI and of hormonal mediators associated with morbid obesity are outlined. Furthermore,the complications and long-term results of GB are analyzed and compared with laparoscopic gastric bypass in order to define the limits of GB.
Hesse
Uwe J
UJ
Klinik fur Allgemein- und Viszeralchirurgie, Krankenhaus Bad Cannstatt, Klinikum Stuttgart, Deutschland. uhesse@klinikum-stuttgart.de
Gartner
Daniel
D
D015992:Body Mass Index; D015390:Gastric Bypass / Q000009:adverse effects / Q000379:methods*; D015391:Gastroplasty / Q000009:adverse effects / Q000379:methods*; D006728:Hormones / Q000378:metabolism; D006801:Humans; D010535:Laparoscopy / Q000009:adverse effects; D009767:Obesity, Morbid / Q000378:metabolism / Q000601:surgery*; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome; D015431:Weight Loss
D006728:Hormones